Status
Conditions
Treatments
About
mCIMT and BIT are therapies applied in children with hemiplegia which have a great evidence, but not in a early age. This research has the objective to know the effects of this therapies in infants diagnosed of infantile hemiplegia from 9 to 18 months applying 50 hours of dose for both interventions during 10 weeks, executing them at home by families.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10 participants in 4 patient groups
Loading...
Central trial contact
Elena Pinero-Pinto, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal